Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
264.86 INR | +2.51% | +8.78% | +63.72% |
Aug. 21 | Marksans Pharma Arm Gets UK Regulator's Marketing Nod for Fluoxetine Capsules | MT |
Aug. 20 | Marksans Pharma Gets US FDA's EIR for Goa, India Unit | MT |
P/E ratio | Price to Book | PEG | EV / Sales | EV / EBITDA | EV / EBIT | Yield (Y) | Capi. ($) | ||
---|---|---|---|---|---|---|---|---|---|
30.83x | 4.927 | 1.32x | 4.19x | 20.02x | 22.06x | - | 1.42B | ||
58.18x | 40.10 | 0.35x | 18.04x | 43.81x | 47.61x | +0.58% | 813B | ||
38.81x | 27.20 | 1.77x | 13.49x | 27.47x | 30.48x | +1.29% | 582B | ||
21.05x | 5.601 | -0.49x | 4.55x | 12.91x | 14.61x | +2.85% | 396B | ||
37.64x | 40.88 | 0.42x | 7.13x | 15.41x | 15.98x | +3.22% | 342B | ||
15.71x | 6.086 | 0x | 4.99x | 11.43x | 12.92x | +2.61% | 299B | ||
16.36x | 6.070 | 0.96x | 3.88x | 10.15x | 11.28x | +3.59% | 262B | ||
29.75x | 6.131 | 0.64x | 5.34x | 15.82x | 16.45x | +1.85% | 258B | ||
21.17x | 5.316 | -0.94x | 5.01x | 12.68x | 13.36x | +3.22% | 237B | ||
48.68x | 34.31 | -1.03x | 6.7x | 11.8x | 14.95x | +2.86% | 172B | ||
20.97x | 1.846 | 0.08x | 3.62x | 9.9x | 11.88x | +5.89% | 162B | ||
19.88x | 1.713 | 0.9x | 2.94x | 10.17x | 11.11x | +3.67% | 145B | ||
-24.69x | 5.250 | 0.16x | 2.94x | 25.59x | 30.12x | +4.91% | 98.73B | ||
292.42x | 4.978 | -3.11x | 4.16x | 11.42x | 15.53x | +3.91% | 98.01B | ||
13.04x | 4.262 | 3.15x | 2.51x | 7.43x | 8.6x | +3.65% | 88.59B | ||
29.72x | 5.868 | 2.5x | 8.93x | 18.8x | 20.14x | +1.32% | 76.16B | ||
49.82x | 6.393 | 6.04x | 5.45x | 32.23x | 40.3x | +1.07% | 75.52B | ||
60.04x | 0.9294 | -2.64x | 2.45x | 10.27x | 36.81x | +4.59% | 47.63B | ||
24.68x | 2.093 | 0.62x | 3.78x | 14.96x | 16.79x | +1.64% | 46.75B | ||
Average | 42.32x | 11.05 | 0.56x | 5.79x | 16.96x | 20.58x | +2.93% | 221.07B | |
Weighted average by Cap. | 39.25x | 18.99 | 0.47x | 8.64x | 21.34x | 23.91x | +2.40% |
- Stock Market
- Equities
- MARKSANS Stock
- Sector Marksans Pharma Limited
- Sector valuations